Cristina Guarducci

1.0k total citations
27 papers, 552 citations indexed

About

Cristina Guarducci is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Cristina Guarducci has authored 27 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Cristina Guarducci's work include Advanced Breast Cancer Therapies (22 papers), Cancer-related Molecular Pathways (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Cristina Guarducci is often cited by papers focused on Advanced Breast Cancer Therapies (22 papers), Cancer-related Molecular Pathways (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Cristina Guarducci collaborates with scholars based in Italy, United States and Belgium. Cristina Guarducci's co-authors include Ilenia Migliaccio, Luca Malorni, Angelo Di Leo, Martina Bonechi, Christopher D. Hart, Laura Biganzoli, Chiara Biagioni, Matteo Benelli, Roberto Verardo and Giulia Boccalini and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Cristina Guarducci

23 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cristina Guarducci Italy 11 405 401 207 134 129 27 552
Carla L. Alves Denmark 9 200 0.5× 188 0.5× 120 0.6× 165 1.2× 49 0.4× 20 373
Patricia Sung United States 7 281 0.7× 286 0.7× 299 1.4× 275 2.1× 49 0.4× 12 568
Sun Min Lim South Korea 5 359 0.9× 291 0.7× 108 0.5× 153 1.1× 41 0.3× 8 497
Kristi Gramlich United States 3 320 0.8× 274 0.7× 55 0.3× 111 0.8× 80 0.6× 4 386
Núria Chic Spain 9 322 0.8× 252 0.6× 211 1.0× 173 1.3× 70 0.5× 53 502
Andrew Foxley United Kingdom 8 211 0.5× 275 0.7× 112 0.5× 192 1.4× 54 0.4× 20 385
Sharmeen Uddin United States 5 247 0.6× 238 0.6× 149 0.7× 263 2.0× 28 0.2× 7 498
Christopher Colameco United States 5 291 0.7× 290 0.7× 69 0.3× 44 0.3× 80 0.6× 9 341
Germira Di Gioia Italy 7 174 0.4× 188 0.5× 127 0.6× 151 1.1× 38 0.3× 7 391
Magdalena Čížková Czechia 6 160 0.4× 127 0.3× 166 0.8× 292 2.2× 56 0.4× 9 429

Countries citing papers authored by Cristina Guarducci

Since Specialization
Citations

This map shows the geographic impact of Cristina Guarducci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina Guarducci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina Guarducci more than expected).

Fields of papers citing papers by Cristina Guarducci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristina Guarducci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina Guarducci. The network helps show where Cristina Guarducci may publish in the future.

Co-authorship network of co-authors of Cristina Guarducci

This figure shows the co-authorship network connecting the top 25 collaborators of Cristina Guarducci. A scholar is included among the top collaborators of Cristina Guarducci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristina Guarducci. Cristina Guarducci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Migliaccio, Ilenia, Cristina Guarducci, & Luca Malorni. (2025). CDK4/6 Inhibitor Resistance in ER+ Breast Cancer. Advances in experimental medicine and biology. 1464. 475–493.
2.
3.
Migliaccio, Ilenia, Martina Bonechi, Dario Romagnoli, et al.. (2025). Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines. npj Breast Cancer. 11(1). 82–82.
4.
Grinshpun, Albert, Wen Ma, Giorgio Gaglia, et al.. (2024). Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer. npj Breast Cancer. 10(1). 42–42. 3 indexed citations
5.
Migliaccio, Ilenia, Dario Romagnoli, Francesca Galardi, et al.. (2024). Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial. JCO Precision Oncology. 8(8). e2300285–e2300285. 4 indexed citations
6.
Stein, Shayna, Agostina Nardone, Weihan Liu, et al.. (2023). Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor–positive Breast Cancer. Cancer Research Communications. 3(11). 2331–2344. 5 indexed citations
7.
Migliaccio, Ilenia, Angela Leo, Francesca Galardi, et al.. (2021). Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer. Cancers. 13(11). 2640–2640. 8 indexed citations
8.
Galardi, Francesca, Francesca De Luca, Chiara Biagioni, et al.. (2021). Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial. Breast Cancer Research. 23(1). 38–38. 25 indexed citations
9.
Migliaccio, Ilenia, Martina Bonechi, Amelia McCartney, et al.. (2020). CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancer. Cancer Treatment Reviews. 93. 102136–102136. 21 indexed citations
10.
Bonechi, Martina, Ilenia Migliaccio, Matteo Benelli, et al.. (2019). Abstract P6-09-02: Effects of palbociclib on thymidine kinase-1 (TK1) in hormone receptor positive (HR+) breast cancer cell lines. Cancer Research. 79(4_Supplement). P6–9. 2 indexed citations
11.
Guarducci, Cristina, Martina Bonechi, Matteo Benelli, et al.. (2018). Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer. npj Breast Cancer. 4(1). 38–38. 86 indexed citations
12.
Risi, Emanuela, Andrea Grilli, Ilenia Migliaccio, et al.. (2018). A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients. Breast Cancer Research and Treatment. 170(2). 329–341. 18 indexed citations
13.
Guarducci, Cristina, Martina Bonechi, Giulia Boccalini, et al.. (2017). Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response. Breast Care. 12(5). 304–308. 56 indexed citations
14.
15.
Jeselsohn, Rinath, William T. Barry, Ilenia Migliaccio, et al.. (2016). TransCONFIRM: Identification of a Genetic Signature of Response to Fulvestrant in Advanced Hormone Receptor–Positive Breast Cancer. Clinical Cancer Research. 22(23). 5755–5764. 20 indexed citations
16.
Migliaccio, Ilenia, Luca Malorni, Christopher D. Hart, Cristina Guarducci, & Angelo Di Leo. (2015). Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers. BMC Medicine. 13(1). 46–46. 21 indexed citations
17.
Hart, Christopher D., Ilenia Migliaccio, Luca Malorni, et al.. (2015). Challenges in the management of advanced, ER-positive, HER2-negative breast cancer. Nature Reviews Clinical Oncology. 12(9). 541–552. 119 indexed citations
18.
Malorni, Luca, Chiara Biagioni, Cristina Guarducci, et al.. (2015). AP-2gamma as a novel biomarker of endocrine resistance: Results from the TransCONFIRM study. Annals of Oncology. 26. iii15–iii15. 1 indexed citations
19.
Malorni, Luca, Chiara Biagioni, J. Thirlwell, et al.. (2014). Efficacy of Fulvestrant According to Duration and Type of Adjuvant Endocrine Treatment, in Metastatic Breast Cancer Patients Enrolled in the Confirm Trial. Annals of Oncology. 25. i8–i8. 1 indexed citations
20.
Leo, Angelo Di, Natalie Turner, Luca Malorni, & Cristina Guarducci. (2012). Introduction: Luminal A and B: How Curable are they?. Annals of Oncology. 23. ix27–ix27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla L. Alves Breakdown of academic impact, for papers by Patricia Sung Breakdown of academic impact, for papers by Sun Min Lim Breakdown of academic impact, for papers by Kristi Gramlich Breakdown of academic impact, for papers by Núria Chic Breakdown of academic impact, for papers by Andrew Foxley Breakdown of academic impact, for papers by Sharmeen Uddin Breakdown of academic impact, for papers by Christopher Colameco Breakdown of academic impact, for papers by Germira Di Gioia Breakdown of academic impact, for papers by Magdalena Čížková
Rankless by CCL
2026